| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |